Novartis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.01.06	Hugin-News: Novartis International AG (GlobeNewswire)
12.12.05	Alcon Receives Approval of RETAANE(R) Suspension in Australia (Businesswire)
06.12.05	Alcon Announces Wolfgang Reichenberger to Leave Board (Businesswire)
17.11.05	Positive Opinion For CUBICIN(R) (Daptomycin) Received from European Regulatory Authority; Final EU Approval of Antibiotic Expected in the First Quarter of 2006 (Businesswire)
07.11.05	Alcon Presents New Clinical Data and Provides Regulatory Update on PATANASE(R) Nasal Spray (Businesswire)
31.10.05	Hugin-News: Novartis International AG (GlobeNewswire)
28.10.05	Chiron Announces Promising Data from Clinical Study of Adjuvanted Avian Influenza Vaccine; Results Confirm Previous Clinical Studies: Chiron's MF59 Adjuvant Significantly Enhances Immune Response (Businesswire)
27.10.05	Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile; Contract with U.S. Department of Health & Human Services for H5N1 Stockpile (Businesswire)
25.10.05	Chiron Reports Third-Quarter 2005 Adjusted Earnings of $0.38 per Share, GAAP Earnings of $0.27 per Share (Businesswire)
20.10.05	Dharmacon und Alcon werden bei der Entdeckung neuer, RNAi-basierter Therapien für Augenerkrankungen zusammenarbeiten (PR Newswire)
19.10.05	Alcon's Third Quarter Earnings Rise 52.2 Percent on 11.8 Percent Sales Growth (Businesswire)
17.10.05	Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customers; First Shipments Mark Beginning of 2005-2006 FLUVIRIN Supply (Businesswire)
13.10.05	Safety of Alcon's RETAANE(R) Suspension Confirmed at 24 Months; Data Supports Clinical Equivalence to VISUDYNE (Businesswire)
13.10.05	Chiron and XOMA Announce Initiation of Phase I Clinical Trial for CHIR-12.12 in Multiple Myeloma -- Second Clinical Trial Evaluating Oncology Drug Candidate Begins (Businesswire)
12.10.05	FDA Approves Alcon's OPTI-FREE(R) RepleniSH(R) MPDS (Businesswire)
20.09.05	Hugin-News: Novartis International AG (GlobeNewswire)
27.07.05	Chiron Reports Second-Quarter 2005 Adjusted Earnings of $0.08 Per Share, GAAP Earnings of Less Than $0.01 Per Share; 10 Percent Increase in Revenues Over Second-Quarter 2004 (Businesswire)
19.05.05	Chiron and Enanta Announce Agreement for Development and Commercialization of HCV Therapeutics; Enanta Granted Worldwide License to Chiron's Portfolio of Hepatitis C Protease Inhibitors (Businesswire)
11.05.05	CMS Ruling Provides Medicare Patients Access to Alcon's AcrySof ReSTO (Businesswire)
03.05.05	Chiron Foundation Awards Four Grants to Aid New Approaches in Medical (Businesswire)
27.04.05	Chiron Reports First-Quarter 2005 Pro-Forma Earnings of 4 Cents Per Sh (Businesswire)
26.04.05	Hugin-News: Novartis AG (GlobeNewswire)
26.04.05	Chiron to Present at Deutsche Bank Healthcare Conference (Businesswire)
18.04.05	NEVANAC Suspension Clinical Data Presented at Eye Care Conference; FDA (Businesswire)
14.04.05	Chiron Signs Contract with South African National Blood Service (Businesswire)
23.03.05	FDA Approves Alcon's AcrySof ReSTOR Intraocular Lens (Businesswire)
08.03.05	Chiron Revises Full-Year 2004 Pro-Forma Earnings From 70 Cents to 67 C (Businesswire)
03.03.05	REMINDER/Chiron to Hold Press Conference to Discuss FLUVIRIN Influenza (Businesswire)
03.03.05	ADVISORY/Chiron to Hold Press Conference to Discuss FLUVIRIN Influenza (Businesswire)
03.03.05	Chiron to Hold Investor Conference Call to Discuss FLUVIRIN Influenza (Businesswire)
25.02.05	New RETAANE Clinical Study Data Reported at Macula Society Meeting (Businesswire)
23.02.05	Chiron Appoints Jack Goldstein President and Chief Operating Officer; (Businesswire)
09.02.05	Alcon's Fourth Quarter Earnings Rise 39.9 Percent on 11.9 Percent Sal (Businesswire)
26.01.05	Chiron Reports 2004 Pro-Forma Earnings Results of 70 Cents Per Share; (Businesswire)
26.01.05	William Blair & Company Initiates Coverage of Alcon, Inc. With Market (PR Newswire)
12.01.05	Chiron Anticipates a Series of Regulatory Inspections for Remediation (Businesswire)
12.01.05	Chiron to Release Earnings on Wednesday, January 26, 2005; Conference (Businesswire)
05.01.05	Chiron to Present at 23rd Annual JPMorgan Healthcare Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	545.60	2.17 %	K V
Sika	235.80	1.51 %	K V
CieFinRichemont	127.65	1.43 %	K V
Part Grp Hldg	1’299.50	1.33 %	K V
Holcim	91.86	1.15 %	K V
Roche Hldg G	254.50	-0.66 %	K V
Lonza Grp	525.00	-0.72 %	K V
Sonova Hldg	297.70	-1.03 %	K V
Alcon	77.12	-1.20 %	K V
Swiss Life Hldg	690.40	-4.69 %	K V

mehr

19:37		TELL me! - der Schweizer Trading Podcast: Ausblick 2025: stabil bis positiv - Dividenden Titel: Coca-Cola, Sanofi und Evonik
18:01		Minuszeichen in New York: Dow Jones präsentiert sich mittags leichter
18:01		NASDAQ Composite-Handel aktuell: NASDAQ Composite legt zu
17:58		STOXX-Handel: STOXX 50 zum Handelsende im Aufwind
17:58		SPI-Handel aktuell: SPI steigt zum Ende des Dienstagshandels
17:58		Freundlicher Handel in Frankfurt: TecDAX letztendlich freundlich
17:58		Euro STOXX 50-Handel aktuell: Euro STOXX 50 zum Ende des Dienstagshandels mit Gewinnen

19:37

TELL me! - der Schweizer Trading Podcast: Ausblick 2025: stabil bis positiv - Dividenden Titel: Coca-Cola, Sanofi und Evonik

18:01

Minuszeichen in New York: Dow Jones präsentiert sich mittags leichter

18:01

NASDAQ Composite-Handel aktuell: NASDAQ Composite legt zu

17:58

STOXX-Handel: STOXX 50 zum Handelsende im Aufwind

17:58

SPI-Handel aktuell: SPI steigt zum Ende des Dienstagshandels

17:58

Freundlicher Handel in Frankfurt: TecDAX letztendlich freundlich